NEW Bruker Biotyper Service Contract

The contract pertains to a service agreement for the Bruker Biotyper system identified by serial number 604562-01608, under the title "NEW Bruker Biotyper Service Contract." It is a forecasted opportunity posted on March 11, 2026, by the Food and Drug Administration (FDA), specifically under the NAICS code 811219, which corresponds to other electronic and precision equipment repair and maintenance services. The contract aims to ensure ongoing maintenance and support for the Biotyper system, likely involving equipment servicing, troubleshooting, and possibly software updates to maintain optimal performance in FDA operations. Key points include the absence of a specified place of performance or detailed set-aside type, indicating an open competition. The point of contact for program inquiries is the NCTR Acquisition Liaison via email, while the contracting officer is yet to be determined. This contract is essential for sustaining the operational capabilities of the Biotyper system, which is critical in FDA’s laboratory or diagnostic functions, and reflects the agency's commitment to maintaining advanced scientific equipment through authorized service agreements.